# FLUOROQUINOLONE TOXICITY AND RESEARCH

## Details

- **Country:** England & Wales
- **Charity number:** 1207313
- **Status:** Registered
- **Legal form:** Charitable company
- **Registered:** March 5, 2024
- **Register:** https://register-of-charities.charitycommission.gov.uk/en/charity-search/?p_p_id=uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet&p_p_lifecycle=0&p_p_state=maximized&p_p_mode=view&_uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet_regId=1207313


## Contact

- **Address:** 200 TOOTING HIGH STREET, LONDON
- **Postcode:** SW17 0SF
- **Phone:** 07710902252
- **Email:** fluoroqtoxity@gmail.com



## Activities

**Objects:** THE RELIEF OF SICKNESS AND THE ADVANCEMENT OF HEALTH OF THOSE WITH FLUOROQUINOLONE TOXICITY BY:- PROVIDING FUNDS TO FLUOROQUINOLONE TOXICITY PATIENTS TOWARDS THE COST OF TREATMENT AND OTHER SUPPORT DEEMED APPROPRIATE BY THE TRUSTEES- PROMOTING RESEARCH INTO THE UNDERSTANDING, DIAGNOSIS, CAUSE, AND TREATMENT OF FLUOROQUINOLONE TOXICITY THROUGH THE PROVISION OF GRANTS RELATED TO RESEARCH PROJECTS THE RESULTS OF WHICH ARE DISSEMINATED FOR PUBLIC BENEFIT.

**Activities:** The charity aims to relieve sickness and advance the health of those suffering with fluoroquinolone toxicity by providing funds to patients towards the cost of their treatment and by providing donations to research projects promoting research into the diagnosis, cause and treatment of such patients.




## Classification

- **How:** Makes Grants To Individuals, Makes Grants To Organisations, Sponsors Or Undertakes Research
- **What:** General Charitable Purposes, The Advancement Of Health Or Saving Of Lives
- **Who:** Other Defined Groups



## Areas of operation

- Throughout England



## Finances

| Period end | Income | Expenditure | Assets | Employees |
|---|---|---|---|---|
| Aug. 31, 2025 | £3000 | £7624 | — | — |
| Aug. 31, 2024 | £70000 | £70313 | — | — |



## Trustees

- **Matheo Matheou** (Chair) — appointed April 5, 2024
- Christina Matheou — appointed April 5, 2024
- Penelope Moore — appointed Aug. 6, 2024